AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2011
Apr 21, 2011
31982_dirs_2011-04-21_9edbe603-c475-43d7-92d5-71be80c3b026.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2011-04-19
Reporting Person: YOUNG JAMES F (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-19 | Options right to buy | $2.57 | A | 200000 | Acquired | 2021-04-19 | Common Stock (200000) | Direct |
Footnotes
F1: The option to purchase 20,000 shares of common stock shall become exercisable 6 months from date of grant.